| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.09 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.079 | 0.1 |